Animal models of immune-mediated neuropathies

Current Opinion in Neurology

Volumn 15, Issue 5, 2002, Pages 617-622

  Mäurer, Mathias ^a   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Animal models; Experimental autoimmune neuritis; Genetics

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; GUILLAIN BARRE SYNDROME; IMMUNE MEDIATED NEUROPATHY; IMMUNITY; IMMUNOTHERAPY; MOUSE; NEURITIS; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; RAT; REVIEW;

ANIMALS; HUMANS; MICE; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS;

EID: 0036797548     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200210000-00013     Document Type: Review

References (51)

1. Hartung HP, van der Meche FG, Pollard JD. Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies [Editorial]. Curr Opin Neurol 1998; 11:497-513.
2. Kieseier BC, Clements JM, Pischel HB, et al. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann Neurol 1998; 43:427-434.
3. Huang D, Han Y, Rani MR, et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 2000; 177:52-67.
4. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 1999; 100:74-97.
5. Kiefer R, Kieseier BC, Stoll G, Hartung H. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 2001; 64:109-127.
6. Buchwald B, Toyka KV, Zielasek J, et al. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol 1998; 44:913-922.
7. Gold R, Hartung H-P, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000; 6:88-91.
8. Waksman BH, Adams RD. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 1955; 102:213-236.
9. Gold R, Archelos J J, Hartung HP. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol 1999; 9:343-360.
10. Milner P, Lovelidge CA, Taylor WA, Hughes RA. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987; 79:275-285.
11. Gabriel CM, Hughes RAC, Moore SE, et al. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 1998; 121:1895-1902.
12. Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981; 11:195-199.
13. Olee T, Powell HC, Brostoff SW. New minimum length requirement for a T cell epitope for experimental allergic neuritis. J Neuroimmunol 1990; 27:187-190.
14. Linington C, Lassmann H, Ozawa K, et al. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992; 22:1813-1817.
15. Linington C, Mann A, Izumo S, et al. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease. J Immunol 1986; 137:3826-3831.
16. Abromson-Leeman S, Bronson R, Dorf ME. Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones. J Exp Med 1995; 182:587-592.
17. Weerth S, Berger T, Lassmann H, Linington C. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. J Neuroimmunol 1999; 95:157-164.
18. Schmidt S. Candidate autoantigens in multiple sclerosis. Mult Scler 1999; 5:147-160.
19. Harvey GK, Gold R, Toyka KV, Hartung HP. Nonneural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain 1995; 118:1263-1272.
20. Pollard JD, Westland KW, Harvey GK, et al. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann Neurol 1995; 37:467-475.
21. Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 1989; 8:3-15.
22. Oldstone MBA, Von Herrath M, Evans CF, Horwitz MS. Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 1996; 206:67-83.
23. Stoll G, Schwendemann G, Heininger K, et al. Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. J Neurol Neurosurg Psychiatry 1986; 49:258-264.
24. Hartung HP, Stoll G, Toyka KV. Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, et al. editors. Peripheral neuropathy. Philadelphia: WB Saunders Company; 1993. pp. 418-444.
25. McCombe PA, Harness J, Pender MP. Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol 1999; 97:60-69.
26. Lassmann H, Fierz W, Neuchrist C, Meyermann R. Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 1991; 114(Pt 1B):429-442.
27. Yuki N, Yamada M, Koga M, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001; 49:712-720.
28. Taylor WA, Hughes RA. Experimental allergic neuritis induced in SJL mice by bovine P2. J Neuroimmunol 1985; 8:153-157.
29. Dieperink ME, ONeill A, Maselli R, Stefansson K. Experimental allergic neuritis in the SJL/J mouse: dysfunction of peripheral nerve without clinical signs. J Neuroimmunol 1991; 35:247-259.
30. Calida DM, Kremlev SG, Fujioka T, et al. Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12. J Neuroimmunol 2000; 107:1-7.
31. Zhu J, Nennesmo I, Deng GM, et al. Induction of experimental autoimmune neuritis in CD4-8-C57BL/6J mice. J Neuroimmunol 1999; 94:196-203.
32. Zou LP, Ljunggren HG, Levi M, et al. P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice. J Neurosci Res 2000; 62:717-721.
33. Zhu J, Zou L, Zhu S, et al. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice. J Neuroimmunol 2001; 115:111-117.
34. Salomon B, Rhee L, Bour-Jordan H, et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 2001; 194:677-684.
35. Chitnis T, Najafian N, Abdallah KA, et al. CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001; 107:575-583.
36. Karandikar NJ, Vanderlugt CL, Eagar T, et al. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J Immunol 1998; 161:192-199.
37. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2:816-822.
38. Reilly MM. Classification of the hereditary motor and sensory neruopathies. Curr Opin Neurol 2000; 13:561-564.
39. Martini R. Animal models for inherited peripheral neuropathies. J Anat 1997; 191:321-336.
40. Martini R. Animal models for inherited peripheral neuropathies: chances to find treatment strategies? J Neurosci Res 2000; 61:244-250.
41. Schmid CD, Stienekemeier M, Oehen S, et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 2000; 20:729-735.
42. Mäurer M, Schmid CD, Bootz F, et al. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Mol Cell Neurosci 2001; 17:1094-1101.
43. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33:333-342.
44. Carenini S, Mäurer M, Werner A, et al. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol 2001; 152:301-308.
45. Smith ME. Phagocytosis of myelin in demyelinative disease: a review. Neurochem Res 1999; 24:261-268.
46. Kobsar I, Mäurer M, Ott T, Martini R. Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci Lett 2002; 320:17-20.
47. Schmidt B, Toyka KV, Kiefer R, et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996; 19:474-487.
48. Shy ME, Arroyo E, Sladky J, et al. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 1997; 56:811-821.
49. Malandrini A, Villanova M, Dotti MT, Federico A. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease. Neurology 1999; 52:859-861.
50. Dyck PJ, Swanson CJ, Low PA, et al. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 1982; 57:239-246.
51. Marques W, Hanna MG, Marques SR, et al. Phenotypic variation of a new P0 mutation in genetically identical twins. J Neurol 1999; 246:596-599.